Pure Global
NCT05706896

Atrophic Age-related Macular Degeneration (AMD) Treated With Intravitreal Injections of Umbilical Cord Blood Platelet-rich Plasma (CB-PRP): a Pilot Study

Fondazione Policlinico Universitario Agostino Gemelli IRCCS·ClinicalTrials.gov·procedureRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Dry Age-related Macular Degeneration
Drug/Device/Intervention
Intravitreal injection of CB-PRP
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Location
Rome, Italy
Timeline & enrollment
Phase
N/A
Start date
Dec 14, 2022
End date
Jun 10, 2023
Enrollment
36 participants
Primary outcome

Autofluorescence atrophy area changes in treated eyes compared with sham group,Autofluorescence atrophy area changes in treated eyes compared with sham group (1)

Summary

The objective of the study will be to evaluate the efficacy of intravitreal injections of
 Umbilical Cord Blood Platelet-rich Plasma (CB-PRP) in order to reduce or stabilize the
 atrophic progression in dry Age-related Macular Degeneration (AMD)

ICD-10 classifications
Peripheral retinal degenerationCorneal degenerationHereditary retinal dystrophyOptic atrophy in diseases classified elsewhereDisorders of choroid and retina
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05706896
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05706896 through Pure Global AI's free database. This phase not specified trial is sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS and is currently Recruiting. The study focuses on Dry Age-related Macular Degeneration. Target enrollment is 36 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.